CMIC Group: Solutions from Japan to the US

Click here to subscribe to Fiercebiotech.com

3 years ago

Html
Text

Download Whitepaper

This week's Fierce Biotech is brought to you by CMIC Group.
Trouble viewing? Click here.

[OnDemand Webinar] Overcoming Challenges of Bioanalytical Method Development for Oligonucleotides and Large Molecules
Alongside large molecule drug development, oligonucleotide therapeutics is also emerging as an established and validated class of drugs that can modulate a multitude of genetic targets. View our recent webinar as the CMIC experts discuss the following: Developing an immunogenicity assay in a regulated laboratory Selecting a format for the neutralization assay for immunogenicity assessments Quantitative Bioanalysis of Oligonucleotides by LC-MS

[Whitepaper] Drug Manufacturing And Development In The Age Of Precision Medicine

Development and Manufacturing: Insights into the Precision Medicine Model

Download this whitepaper for an essential exploration of the concerns and challenges of drug development and manufacturing as it pertains to precision medicine.

You’ll explore topics like:

Improving health outcomes Formulating precision medicines Supporting the precision medicine agenda from start to finish Innovations in drug development and manufacturing Microneedles and more

Tell us about your current project needs
Your needs are important, our goal is to tailor our solutions to fit those unique needs. CMIC offers quality, flexibility and innovative concepts to help accelerate your drug development timeline.

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.

You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor
New York, NY 10017

Share on

Other newsletters from Fiercebiotech.com

| 11.27.24 | Novartis plots field sales layoffs linked to Xolair, cancer combo; Trump picks Stanford economist to helm NIH Fiercebiotech.com
Last Wednesday at 19:26
| 11.27.24 | Trump names NIH pick; PTC axes ALS program, gains $150M in voucher sale Fiercebiotech.com
Last Wednesday at 17:10
| 11.26.24 | Amgen’s obesity data disappoint investo rs; Guardant awarded $292M in false advertising suit Fiercebiotech.com
Last Tuesday at 20:46

More newsletters from Fiercebiotech.com

CMIC Group: Solutions from Japan to the US

Share on

Other newsletters from Fiercebiotech.com

Related newsletters